Radiographic and clinical outcomes of the treatment of immature permanent teeth by revascularization or apexification: a pilot retrospective cohort study.
Radiographic and clinical outcomes of the treatment of immature permanent teeth by revascularization or apexification: a pilot retrospective cohort study.
复制标题
DOI:
10.1016/j.joen.2014.02.016
复制
发表时间:
2014-08
影响因子:
4.2
通讯作者:
Gibbs JL
中科院分区:
文献类型:
--
作者:
Alobaid AS;Cortes LM;Lo J;Nguyen TT;Albert J;Abu-Melha AS;Lin LM;Gibbs JL
This retrospective cohort study compared clinical and radiographic outcomes of endodontic treatment performed in immature non-vital permanent teeth, by apexification (calcium hydroxide or apical barrier with Mineral Trioxide Aggregate (MTA)), versus revascularization. A comprehensive chart review was performed to obtain a cohort of sequential previously completed cases with recalls. Clinical and radiographic data were collected for 31 treated teeth (19 revascularization and 12 apexification) with an average follow up time of 17 months and a recall rate of 63%. Tooth survival, success rate, and adverse events were analyzed. Changes in radiographic root length, width and area were quantified. The majority of treated teeth survived throughout the study period with 30/31 (97%) teeth surviving (18/19 (95%) revascularization, 12/12 apexification). Most cases were also clinically successful with 27/31 (87%) meeting criteria for success, (15/19 (78%) revascularization and 12/12 apexification; non-significant difference). A greater incidence of adverse events was observed in the revascularization group (8/19 (42%) versus 1/12 (11%) in apexification (Risk Ratio= 5.1, p=0.04, 95%CI (0.719, 35.48)). Although more revascularization cases than apexification cases demonstrated an increase in radiographic root area and width, the effect was not statistically significant. In this study, revascularization was not superior to other apexification techniques in either clinical or radiographic outcomes. Studies with large subject cohorts, and long follow up periods are needed to evaluate outcomes of revascularization and apexification, while accounting for important co-variants relevant to clinical success.
登录
查看更多内容
影响因子:
4.2
作者:
Martin, Gabriela;Ricucci, Domenico;Lin, Louis M.
通讯作者:
Lin, Louis M.
影响因子:
4.2
作者:
Chueh, Ling-Huey;Huang, George T. J.
通讯作者:
Huang, George T. J.
影响因子:
4.2
作者:
Holden, David T.;Schwartz, Scott A.;Schindler, William G.
通讯作者:
Schindler, William G.
影响因子:
2.5
作者:
Andreasen, JO;Farik, B;Munksgaard, C
通讯作者:
Munksgaard, C
影响因子:
4.2
作者:
Bose, Raison;Nummikoski, Pirkka;Hargreaves, Kenneth
通讯作者:
Hargreaves, Kenneth